Third Point 13F holdings, Q2 2010
Holdings as of June 30, 2010 · filings on SEC EDGAR · latest filing →
Third Point disclosed 20 US equity positions worth $612.8m in its Q2 2010 13F filing. The largest position was ALCON INC at 14.5% of the reported book, followed by CIT GROUP INC and PHH CORP. Against the Q1 2010 filing, it opened 3 new positions, added to 5 and reduced 6 among the top 20 holdings.
What did Third Point own in Q2 2010? Top 20 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2010 |
|---|---|---|---|---|---|---|---|
| 1 | ALCON INC | 14.5% | $89.1m | 700,000 | 115% | added | |
| 2 | CIT GROUP INC | 13.5% | $82.8m | 2,446,500 | 4% | added | |
| 3 | PHH CORP | 13.0% | $79.4m | 4,170,200 | -7% | reduced | |
| 4 | LIBERTY MEDIA CORP NEW INT | 8.6% | $52.5m | 5,000,000 | 4% | added | |
| 5 | COCA COLA ENTERPRISES INC | 8.4% | $51.8m | 2,002,000 | 0% | held | |
| 6 | M MACYS INC | Consumer Cyclical | 7.6% | $46.5m | 2,600,000 | 333% | added |
| 7 | ASPEN TECHNOLOGY INC | 6.2% | $38.0m | 3,491,200 | -30% | reduced | |
| 8 | XEROX CORP | 5.9% | $36.2m | 4,500,000 | -36% | reduced | |
| 9 | NABI BIOPHARMACEUTICALS | 4.1% | $25.0m | 4,600,100 | -22% | reduced | |
| 10 | DEPOMED INC | 3.1% | $19.0m | 6,790,000 | 0% | held | |
| 11 | XERIUM TECHNOLOGIES INC | 3.0% | $18.3m | 1,294,507 | – | new | |
| 12 | PHH CORP | 2.7% | $16.3m | 15,000,000 | – | new | |
| 13 | RF MICRODEVICES INC | 2.4% | $14.9m | 3,800,000 | -24% | reduced | |
| 14 | ABRAXAS PETE CORP | 2.0% | $12.3m | 4,801,054 | 0% | held | |
| 15 | PLAINS EXPL& PRODTN CO | 1.3% | $8.2m | 400,000 | – | new | |
| 16 | BIOFUEL ENERGY CORP | 1.2% | $7.4m | 5,578,800 | 0% | held | |
| 17 | AMD ADVANCED MICRO DEVICES INC | Technology | 1.2% | $7.3m | 1,000,000 | -56% | reduced |
| 18 | EMMIS COMMUNICATIONS CORP | 0.8% | $4.8m | 216,000 | 5% | added | |
| 19 | LIGAND PHARMACEUTICALS INC | 0.5% | $2.9m | 2,007,378 | 0% | held | |
| 20 | VANTAGE DRILLING COMPANY *W EXP 05/24/201 | 0.0% | $38.0k | 1,875,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.